🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 receptor agonists and thyroid C-cell concerns — what worked for you? Page 3

GLP-1 receptor agonists and thyroid C-cell concerns — what worked for you?

pam_columbus Sun, Dec 21, 2025 at 7:19 PM 11 replies 1,075 viewsPage 3 of 3
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Dec 24, 2025 at 5:41 PM#11
pete_nash said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

6 6Dr.NateNeph, PharmD_Rodriguez, julia.endo and 3 others
Reply Quote Save Share Report
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
Dec 26, 2025 at 4:43 PM#12
LondonLisa said:
Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were…

This answered a question I did not know how to ask.

5 5Dr.EndoEP, GraceAZ_72, carl_compliance and 2 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Dec 28, 2025 at 3:44 PM#13
pete_nash said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

I do not accept the framing. The question has been narrowed to the version that has a tidy answer, and the part that was dropped is the part the OP actually asked about.

4 4james_edin, FranDenver, Dr.BariatricHTX and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Dec 30, 2025 at 2:44 PM#14

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Dec 30, 2025 at 6:44 PM
3 3MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 1, 2026 at 1:43 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Tagging this one for the weekly digest.

2 2PeptideSynthNJ, Dr.KarenChen
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register